Which drugs does patent 6,121,291 protect, and when does it expire?
Patent 6,121,291 protects PAXIL and PAXIL CR and is included in four NDAs. There have been zero Paragraph IV challenges on Paxil CR and
Protection for PAXIL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eight patent family members in seven countries.
This patent has expired prematurely due to non-payment of maintenance fees. See details below.